Ares Commercial Real Estate (NYSE:ACRE) reported a first-quarter loss as higher credit reserves tied to two large troubled loans weighed on results, while management said it continued to reshape the portfolio through new originations, asset resolutions and reduced office exposure.
Chief Executive O
Arbor Realty Trust (NYSE:ABR) executives said the company is making progress reducing troubled assets but warned that higher long-term rates are extending the timeline for resolutions and weighing on earnings.
On the company’s first-quarter 2026 earnings call, President and Chief Executive Officer
Trevi Therapeutics (NASDAQ:TRVI) outlined plans to advance Haduvio, its extended-release formulation of nalbuphine, across multiple chronic cough indications, with management emphasizing upcoming clinical trial starts, a specialty commercial strategy and an extended cash runway following a recent fi
Ziff Davis (NASDAQ:ZD) reported a modest decline in first-quarter 2026 revenue from continuing operations, while management emphasized a broader shift in capital allocation that includes stock repurchases, selective acquisitions and potential asset monetization.
Chief Executive Officer Vivek Shah s
Xometry (NASDAQ:XMTR) reported accelerating first-quarter 2026 growth and raised its full-year outlook, citing stronger marketplace activity, expanding buyer adoption and operating leverage across its AI-driven custom manufacturing platform.
Chief Executive Officer Randy Altschuler said the quarter
Zai Lab (NASDAQ:ZLAB) reported a year-over-year decline in first-quarter 2026 product revenue as pressure on ZEJULA weighed on results, while management emphasized progress across its global oncology and immunology pipeline and pointed to multiple upcoming regulatory and clinical milestones.
On the
Zymeworks (NASDAQ:ZYME) reported a wider first-quarter loss as revenue declined from year-earlier milestone payments, while management highlighted regulatory catalysts for zanidatamab, progress across its antibody-drug conjugate pipeline and continued share repurchases.
Chair and CEO Ken Galbraith
The IMF warned that AI-driven cyberattacks could threaten financial stability, with faster exploitation of vulnerabilities and rising systemic risks across global infrastructure.
Carrier Global has underperformed the broader market over the past year, yet Wall Street analysts maintain a moderately optimistic outlook about the stock’s prospects.
Xeris Biopharma (NASDAQ:XERS) reported a sharp increase in first-quarter 2026 revenue and raised the low end of its full-year revenue outlook, citing strong demand for RECORLEV and continued execution across its commercial portfolio.
On the company’s earnings call, Chief Executive Officer John Shan
T. Rowe Price Group (NASDAQ:TROW) held its 2026 annual meeting of stockholders virtually, with Chair, CEO and President Robert Sharps presiding over the proceedings. Stockholders approved all three items presented at the meeting, according to preliminary results announced during the event.
The comp
Xenon Pharmaceuticals (NASDAQ:XENE) said it is preparing to submit a new drug application to the U.S. Food and Drug Administration in the third quarter of 2026 for azetukalner, its investigational anti-seizure medicine, after reporting positive Phase 3 data in focal onset seizures during the first q
TeraWulf (NASDAQ:WULF) said its first-quarter 2026 results reflected a business shifting from Bitcoin mining toward contracted high-performance computing, or HPC, leasing revenue, as management highlighted progress at its Lake Mariner campus and continued demand for power-backed AI infrastructure.
WW International (NASDAQ:WW), operator of WeightWatchers, reaffirmed its 2026 financial outlook after reporting first-quarter results that reflected continued pressure in its legacy behavioral subscription business, offset in part by growth in its clinical weight-management offering and higher-value
Wynn Resorts (NASDAQ:WYNN) executives said the casino operator delivered strong first-quarter results across Las Vegas and Macau while continuing to navigate geopolitical and logistical challenges tied to its planned Wynn Al Marjan resort in the United Arab Emirates.
On the company’s first-quarter
Warner Music Group (NASDAQ:WMG) reported stronger fiscal second-quarter results, with executives saying the company’s growth strategy is gaining traction across streaming, catalog monetization, distribution and cost efficiency.
On the company’s earnings call for the period ended March 31, 2026, CEO
WillScot (NASDAQ:WSC) reported first-quarter 2026 results that management said exceeded its expectations, as stronger large-project activity and rising activations helped offset continued softness in some local markets.
The company raised its full-year outlook, citing improved visibility from its o
Willdan Group (NASDAQ:WLDN) reported a stronger-than-expected start to fiscal 2026, with executives citing margin expansion, improved productivity and rising demand for energy services as key drivers behind a raised full-year outlook.
President and Chief Executive Officer Mike Bieber said the compa
